Aquavan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2009
01220052009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
OBJECTIVE To summarize the published clinical data on fospropofol, critically review the safety and efficacy information, and… (More)
Is this relevant?
Review
2009
Review
2009
The use of propofol presents chemical and clinical concerns, including pain on injection, allergy risks, possible bacteria growth… (More)
Is this relevant?
Review
2008
Review
2008
Propofol (2,6-diisopropylphenol) is inadequably soluble in water and is therefore formulated as a lipid emulsion. This may have… (More)
Is this relevant?
2008
2008
A novel ethyl dioxy phosphate prodrug of propofol (3) was synthesized and characterized in vitro and in vivo as safer alternative… (More)
Is this relevant?
2007
2007
GOAL To determine rapidly acting agents' impact on practice efficiency and cost for outpatient colonoscopy in a screening… (More)
Is this relevant?
Review
2007
Review
2007
Recommendations for routine screening for colorectal cancer with colonoscopy are likely to substantially increase the demand for… (More)
Is this relevant?
Review
2006
Review
2006
PURPOSE OF REVIEW In this review, we summarize the new drugs in development in the anaesthesia field. RECENT FINDINGS There are… (More)
Is this relevant?
Review
2005
Review
2005
GPI-15715 (PQ-1002, Aquavan), a water-soluble prodrug of propofol, is being developed by Guilford, under license from ProQuest… (More)
Is this relevant?